Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Somatix receives patent coverage for GVAX

May 3, 1996

Preclinical results for DC101 presented at AACR

April 26, 1996

GVAX cleared to enter phase III testing

April 26, 1996

Mitsubishi in-licenses anti-HER2, will begin clinical evaluation soon

April 26, 1996

Alnorin reported in phase I

April 19, 1996

BR96 produced successfully in milk from transgenic goats

April 12, 1996

Virulizin clinical trials resume in pancreatic cancer

April 12, 1996

Virulizin clinical trials reinitiated for KS

April 12, 1996

MAbs for treatment of melanoma

April 5, 1996

IDEC-C2B8 development update

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...